JP2022548646A5 - - Google Patents
Info
- Publication number
- JP2022548646A5 JP2022548646A5 JP2022517136A JP2022517136A JP2022548646A5 JP 2022548646 A5 JP2022548646 A5 JP 2022548646A5 JP 2022517136 A JP2022517136 A JP 2022517136A JP 2022517136 A JP2022517136 A JP 2022517136A JP 2022548646 A5 JP2022548646 A5 JP 2022548646A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025099435A JP2025125563A (ja) | 2019-09-16 | 2025-06-13 | 抗幹細胞因子抗体及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962900927P | 2019-09-16 | 2019-09-16 | |
| US62/900,927 | 2019-09-16 | ||
| PCT/US2020/050973 WO2021055408A1 (en) | 2019-09-16 | 2020-09-16 | Anti-stem cell factor antibodies and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025099435A Division JP2025125563A (ja) | 2019-09-16 | 2025-06-13 | 抗幹細胞因子抗体及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548646A JP2022548646A (ja) | 2022-11-21 |
| JP2022548646A5 true JP2022548646A5 (https=) | 2023-09-13 |
| JP7698635B2 JP7698635B2 (ja) | 2025-06-25 |
Family
ID=74868426
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517136A Active JP7698635B2 (ja) | 2019-09-16 | 2020-09-16 | 抗幹細胞因子抗体及びその使用方法 |
| JP2022517173A Active JP7717687B2 (ja) | 2019-09-16 | 2020-09-16 | 腎疾患における抗幹細胞因子抗体及びその使用方法 |
| JP2025099435A Pending JP2025125563A (ja) | 2019-09-16 | 2025-06-13 | 抗幹細胞因子抗体及びその使用方法 |
| JP2025123268A Pending JP2025165991A (ja) | 2019-09-16 | 2025-07-23 | 腎疾患における抗幹細胞因子抗体及びその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517173A Active JP7717687B2 (ja) | 2019-09-16 | 2020-09-16 | 腎疾患における抗幹細胞因子抗体及びその使用方法 |
| JP2025099435A Pending JP2025125563A (ja) | 2019-09-16 | 2025-06-13 | 抗幹細胞因子抗体及びその使用方法 |
| JP2025123268A Pending JP2025165991A (ja) | 2019-09-16 | 2025-07-23 | 腎疾患における抗幹細胞因子抗体及びその使用方法 |
Country Status (28)
| Country | Link |
|---|---|
| US (5) | US20220324957A1 (https=) |
| EP (3) | EP4031569B1 (https=) |
| JP (4) | JP7698635B2 (https=) |
| KR (1) | KR20220079561A (https=) |
| CN (2) | CN118561997A (https=) |
| AR (1) | AR119979A1 (https=) |
| AU (2) | AU2020348295A1 (https=) |
| BR (1) | BR112022004776A2 (https=) |
| CA (2) | CA3154649A1 (https=) |
| CL (1) | CL2022000633A1 (https=) |
| CO (1) | CO2022003661A2 (https=) |
| DK (1) | DK4031569T3 (https=) |
| DO (1) | DOP2022000058A (https=) |
| EC (1) | ECSP22022676A (https=) |
| ES (1) | ES3053942T3 (https=) |
| FI (1) | FI4031569T3 (https=) |
| IL (1) | IL291385A (https=) |
| MX (1) | MX2022003159A (https=) |
| PE (1) | PE20230090A1 (https=) |
| PH (1) | PH12022550647A1 (https=) |
| PL (1) | PL4031569T3 (https=) |
| PT (1) | PT4031569T (https=) |
| SA (1) | SA522431966B1 (https=) |
| TW (2) | TWI875812B (https=) |
| UA (1) | UA129546C2 (https=) |
| UY (1) | UY38883A (https=) |
| WO (2) | WO2021055408A1 (https=) |
| ZA (1) | ZA202203272B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019265019B2 (en) | 2018-05-11 | 2025-11-06 | Beam Therapeutics Inc. | Methods of substituting pathogenic amino acids using programmable base editor systems |
| AU2020348295A1 (en) * | 2019-09-16 | 2022-04-07 | Insmed Incorporated | Anti-stem cell factor antibodies and methods of use thereof |
| KR20250167153A (ko) * | 2023-03-03 | 2025-11-28 | 셀덱스 쎄라퓨틱스, 인크. | 항-줄기 세포 인자(scf) 및 항-흉선 기질 림포포이에틴(tslp) 항체, 및 이중특이적 구축물 |
| WO2026079764A1 (ko) * | 2024-10-10 | 2026-04-16 | 아주대학교산학협력단 | 마우스 scf를 중화하는 항체 및 이의 용도 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| JP2657113B2 (ja) * | 1989-10-16 | 1997-09-24 | アムジエン・インコーポレーテツド | 幹細胞因子 |
| US7144731B2 (en) * | 1989-10-16 | 2006-12-05 | Amgen Inc. | SCF antibody compositions and methods of using the same |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| CA2090126C (en) | 1990-08-02 | 2002-10-22 | John W. Schrader | Methods for the production of proteins with a desired function |
| US5911988A (en) | 1995-04-28 | 1999-06-15 | Bayer Corporation | Method for treating asthma using SCF antibody |
| JP3583214B2 (ja) | 1995-12-01 | 2004-11-04 | 株式会社ニチレイ | ヒトｓｃｆに対するモノクローナル抗体 |
| US20090087878A9 (en) | 1999-05-06 | 2009-04-02 | La Rosa Thomas J | Nucleic acid molecules associated with plants |
| US6399857B1 (en) * | 1999-09-22 | 2002-06-04 | Paradigm Genetics, Inc. | Modified nucleotide sequence encoding a LexA DNA binding domain optimized for arabidopsis species |
| AR037756A1 (es) * | 2001-12-17 | 2004-12-01 | Bayer Corp | Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma. |
| US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
| PL1691837T3 (pl) | 2003-12-10 | 2012-11-30 | Squibb & Sons Llc | IP-10 przeciwciała i ich zastosowanie |
| US7611707B2 (en) | 2004-04-29 | 2009-11-03 | Otsuka Pharmaceutical Co., Ltd. | Glycoprotein VI antibodies and methods thereof |
| WO2006002064A2 (en) | 2004-06-14 | 2006-01-05 | Aerovance, Inc. | Antibody inhibiting stem cell factor activity and use for treatment of asthma |
| US20080248050A1 (en) | 2006-06-30 | 2008-10-09 | Uchicago Argonne, Llc | Meta-specific vaccine, method for treating patients immunized with meta-specific vaccine |
| US20110189093A1 (en) | 2008-04-14 | 2011-08-04 | Proscan Rx Pharma | Prostate specific membrane antigen antibodies and antigen binding fragments |
| AU2012205718B2 (en) | 2011-01-10 | 2017-07-06 | The Regents Of The University Of Michigan | Stem cell factor inhibitor |
| US20150018408A1 (en) | 2013-07-10 | 2015-01-15 | The Regents Of The University Of Michigan | Therapeutic antibodies and uses thereof |
| KR101384360B1 (ko) | 2012-05-04 | 2014-04-14 | 아주대학교산학협력단 | Ｓｃｆ 또는 이의 수용체를 억제하는 물질을 포함하는 혈관 투과성 관련 질환의 치료 또는 예방용 조성물 |
| NZ630363A (en) | 2012-07-25 | 2018-09-28 | Celldex Therapeutics Inc | Anti-kit antibodies and uses thereof |
| US10927153B1 (en) | 2015-05-20 | 2021-02-23 | University Of South Florida | Synthetic plasmodium antigens, compositions, and uses thereof |
| KR102438650B1 (ko) * | 2015-08-19 | 2022-08-31 | 화이자 인코포레이티드 | 조직 인자 경로 억제제 항체 및 그의 용도 |
| KR20170022409A (ko) | 2015-08-20 | 2017-03-02 | 주식회사 와이바이오로직스 | Scf 특이적 항체 |
| US11091559B2 (en) * | 2015-08-27 | 2021-08-17 | Celldex Therapeutics, Inc. | Anti-ALK antibodies and methods for use thereof |
| CA3009488A1 (en) | 2015-12-22 | 2017-06-29 | Abbvie Stemcentrx Llc | Novel anti-upk1b antibodies and methods of use |
| PL3523421T3 (pl) | 2016-10-05 | 2025-06-09 | Cellresearch Corporation Pte. Ltd. | Sposób izolowania mezenchymalnych komórek macierzystych z błony owodniowej pępowiny przy użyciu podłoża do hodowli komórkowej |
| WO2019066093A1 (ko) | 2017-09-26 | 2019-04-04 | 주식회사 와이바이오로직스 | Scf 특이적 항체 |
| WO2019088658A1 (ko) | 2017-10-31 | 2019-05-09 | 주식회사 컴워스파마 | Scf 및 갈렉틴-1을 표적으로 하는 이중표적항체 및 그 용도 |
| KR102131898B1 (ko) | 2017-10-31 | 2020-07-08 | 주식회사 노벨티노빌리티 | Scf 및 갈렉틴-1을 표적으로 하는 이중표적항체 및 그 용도 |
| CA3117098A1 (en) | 2018-10-19 | 2020-04-23 | The General Hospital Corporation | Compositions and methods for treatment of liver disease |
| AU2020348295A1 (en) | 2019-09-16 | 2022-04-07 | Insmed Incorporated | Anti-stem cell factor antibodies and methods of use thereof |
| US20240182556A1 (en) | 2021-03-17 | 2024-06-06 | Opsidio, LLC | Stem cell factor antibodies and methods of use thereof |
-
2020
- 2020-09-16 AU AU2020348295A patent/AU2020348295A1/en active Pending
- 2020-09-16 EP EP20866530.7A patent/EP4031569B1/en active Active
- 2020-09-16 WO PCT/US2020/050973 patent/WO2021055408A1/en not_active Ceased
- 2020-09-16 PE PE2022000419A patent/PE20230090A1/es unknown
- 2020-09-16 MX MX2022003159A patent/MX2022003159A/es unknown
- 2020-09-16 US US17/640,544 patent/US20220324957A1/en active Pending
- 2020-09-16 BR BR112022004776A patent/BR112022004776A2/pt unknown
- 2020-09-16 US US17/022,465 patent/US11939373B2/en active Active
- 2020-09-16 DK DK20866530.7T patent/DK4031569T3/da active
- 2020-09-16 JP JP2022517136A patent/JP7698635B2/ja active Active
- 2020-09-16 UA UAA202201048A patent/UA129546C2/uk unknown
- 2020-09-16 US US17/640,538 patent/US20220340655A1/en not_active Abandoned
- 2020-09-16 EP EP20865210.7A patent/EP4031176A4/en active Pending
- 2020-09-16 FI FIEP20866530.7T patent/FI4031569T3/fi active
- 2020-09-16 CN CN202410508865.2A patent/CN118561997A/zh active Pending
- 2020-09-16 TW TW109131936A patent/TWI875812B/zh active
- 2020-09-16 EP EP25193246.3A patent/EP4650367A3/en active Pending
- 2020-09-16 CA CA3154649A patent/CA3154649A1/en active Pending
- 2020-09-16 PT PT208665307T patent/PT4031569T/pt unknown
- 2020-09-16 WO PCT/US2020/050974 patent/WO2021055409A1/en not_active Ceased
- 2020-09-16 CN CN202080078693.XA patent/CN114729036B/zh active Active
- 2020-09-16 UY UY0001038883A patent/UY38883A/es active IP Right Grant
- 2020-09-16 PH PH1/2022/550647A patent/PH12022550647A1/en unknown
- 2020-09-16 CA CA3154648A patent/CA3154648A1/en active Pending
- 2020-09-16 AR ARP200102566A patent/AR119979A1/es unknown
- 2020-09-16 AU AU2020351138A patent/AU2020351138A1/en active Pending
- 2020-09-16 ES ES20866530T patent/ES3053942T3/es active Active
- 2020-09-16 PL PL20866530.7T patent/PL4031569T3/pl unknown
- 2020-09-16 TW TW114107177A patent/TW202523696A/zh unknown
- 2020-09-16 JP JP2022517173A patent/JP7717687B2/ja active Active
- 2020-09-16 KR KR1020227012536A patent/KR20220079561A/ko active Pending
-
2022
- 2022-03-15 DO DO2022000058A patent/DOP2022000058A/es unknown
- 2022-03-15 CL CL2022000633A patent/CL2022000633A1/es unknown
- 2022-03-15 IL IL291385A patent/IL291385A/en unknown
- 2022-03-16 SA SA522431966A patent/SA522431966B1/ar unknown
- 2022-03-18 ZA ZA2022/03272A patent/ZA202203272B/en unknown
- 2022-03-24 EC ECSENADI202222676A patent/ECSP22022676A/es unknown
- 2022-03-28 CO CONC2022/0003661A patent/CO2022003661A2/es unknown
- 2022-09-06 US US17/929,976 patent/US20230019680A1/en not_active Abandoned
-
2023
- 2023-11-02 US US18/500,622 patent/US12410246B2/en active Active
-
2025
- 2025-06-13 JP JP2025099435A patent/JP2025125563A/ja active Pending
- 2025-07-23 JP JP2025123268A patent/JP2025165991A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022548646A5 (https=) | ||
| US9073999B2 (en) | Anti-IL-17 receptor A neutralizing antibodies | |
| JP2022079549A5 (https=) | ||
| JP2023071956A5 (https=) | ||
| JP2018108081A5 (https=) | ||
| JP2018516853A5 (https=) | ||
| JP2024516595A5 (https=) | ||
| JP2021523913A5 (https=) | ||
| JP2010538608A5 (https=) | ||
| JP2010534478A5 (https=) | ||
| JP2022513043A5 (https=) | ||
| JP2023540526A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JP2022542574A5 (https=) | ||
| JP2023530663A5 (https=) | ||
| TWI572618B (zh) | 對抗介白素－２０之人類化抗體及發炎性疾病之治療 | |
| JP2023511963A5 (https=) | ||
| JP2023508674A5 (https=) | ||
| JP2023520969A5 (https=) | ||
| CN114573702A (zh) | 一种新型肿瘤衔接器治疗药物的开发和应用 | |
| WO2019230856A1 (ja) | Ｎａｖ１．７モノクローナル抗体 | |
| JP2024511027A (ja) | 幹細胞因子抗体及びその使用方法 | |
| JP2019518473A5 (https=) | ||
| JP2020521752A (ja) | グロボｈに対するヒト化抗体および癌治療におけるその使用 | |
| JP2023534458A5 (https=) |